Why is Boston Scientific facing a securities class action lawsuit?

Investors allege Boston Scientific made misleading statements about the strength and sustainability of growth in its U.S. electrophysiology (EP) segment before reporting weaker results.

What is the U.S. electrophysiology segment at Boston Scientific?

The EP segment includes products used to diagnose and treat heart rhythm disorders. It has been a key driver of growth for the company’s cardiovascular business.

Why were investors surprised by Boston Scientific’s earnings results?

Plaintiffs say the company expressed strong confidence in continued EP growth, leaving analysts and investors unprepared for the earnings miss.

What are investors alleging about Boston Scientific’s EP growth?

The lawsuit claims management knew the segment’s growth rate was unsustainable and approaching a slowdown sooner than investors expected.

How do securities class action lawsuits start?

They typically begin when investors file a complaint alleging that a company made false or misleading statements or failed to disclose important information that affected the stock price.

What is a corrective disclosure in a securities lawsuit?

A corrective disclosure is new information released to the market that reveals the truth about prior misleading statements, often triggering a stock price drop.

What happens during the discovery phase of a securities lawsuit?

During discovery, both sides exchange documents, emails, financial records, and testimony to gather evidence related to the alleged misconduct.

How do investors receive money from a securities settlement?

If a settlement is approved by the court, investors submit a claim form documenting their trades, and payments are distributed from the settlement fund.

Boston Scientific Corporation - Faruqi & Faruqi LLP

Boston Scientific Corporation

Join Action

Case Details

Ticker BSX

Class Period 07/23/2025 - 02/03/2026

Lead Plaintiff Deadline 05/04/2026

Days Left to Seek Plaintiff

If you are a Boston Scientific investor who suffered a loss and would like to learn more, you can provide your information below:

If you purchased or acquired securities in Boston Scientific between July 23, 2025 and February 3, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX) and reminds investors of the May 4, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose true state of Boston Scientific’s U.S. EP segment; notably, that management was aware that the segment’s growth rate was unsustainable and that it was approaching an earlier tipping point than the market was anticipating. Due to Defendants’ statements of confidence and lofty expectations, investors and analysts were left surprised by Boston Scientific’s net income miss and underwhelming guidance for the first half of fiscal 2026.

Lead Plaintiff Deadline: May 4, 2026

Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310)
Or submit your information below to learn about your rights.

Join Action

Boston Scientific Corporation

Monetary Losses ($) *

Website URL

First Name *

Last Name *

Telephone *

Email *

Street Address

City

State

Zip Code

Purchases

1	Purchases Options Price per Share Date # of Shares Principal Amount Amount Paid Series or Cusip # of Contracts Price per Contract Exercise Price Expiration Date
1	Purchases Options Price per Share Date # of Shares Principal Amount Amount Paid Series or Cusip # of Contracts Price per Contract Exercise Price Expiration Date

Add Row

Sales

1	Sales Options Price per Share Date # of Shares Principal Amount Amount Paid Series or Cusip # of Contracts Price per Contract Exercise Price Expiration Date
1	Sales Options Price per Share Date # of Shares Principal Amount Amount Paid Series or Cusip # of Contracts Price per Contract Exercise Price Expiration Date

Add Row

Upload your trades here:

Accepted file types: xls, xlsx, doc, docx, pdf, jpg, jpeg, png, Max. file size: 50 MB, Max. files: 5.
You may redact account numbers from your uploaded documents.

File name:

File size:

Select File

Does not establish an attorney-client relationship *

By clicking this box, I acknowledge that this form is not intended to and does not establish an attorney-client relationship between myself and Faruqi & Faruqi LLP, and that the submission or receipt of information via this form, e-mail or telephone does not create an attorney-client relationship.

Case

Users to notify